Edition:
United States

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

5.10USD
20 Jul 2018
Change (% chg)

$-0.05 (-0.97%)
Prev Close
$5.15
Open
$5.10
Day's High
$5.18
Day's Low
$5.10
Volume
8,124
Avg. Vol
52,273
52-wk High
$6.10
52-wk Low
$2.45

Chart for

About

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization,... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $185.30
Shares Outstanding(Mil.): 35.98
Dividend: --
Yield (%): --

Financials

  HBIO.OQ Industry Sector
P/E (TTM): -- 37.53 33.05
EPS (TTM): -0.09 -- --
ROI: -2.59 8.77 13.17
ROE: -4.12 12.58 15.10

BRIEF-Harvard Bioscience Q1 GAAP Loss Per Share $0.11

* HARVARD BIOSCIENCE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 02 2018

BRIEF-Harvard Bioscience Inc Files For Mixed Shelf Of Up To $50 Mln

* HARVARD BIOSCIENCE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Source text (https://bit.ly/2KqwbVG) Further company coverage:

Apr 30 2018

BRIEF-Harvard Bioscience Reports Q4 GAAP Earnings Per Share $0.03

* HARVARD BIOSCIENCE REPORTS FOURTH QUARTER AND YEAR-END 2017 RESULTS

Mar 01 2018

BRIEF-Harvard Bioscience Says Co Entered Into A Financing Agreement

* HARVARD BIOSCIENCE INC - ON JAN 31, 2018, CO ENTERED INTO A FINANCING AGREEMENT - SEC FILING

Feb 02 2018

BRIEF-Harvard Bioscience To Acquire Data Sciences International

* HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC

Jan 22 2018

Earnings vs. Estimates